
ACT-660602 is an orally active антагонист of chemokine рецептор (CXCR3) with an IC50 value of 204 nM. ACT-660602 inhibits T-клетка migration and shows efficacy in acute lung ingury model. ACT-660602 can be used for autoimmune diseases research.
ACT-660602 is an orally active antagonist of chemokine receptor (CXCR3) with an IC50 value of 204 nM. ACT-660602 inhibits T-cell migration and shows efficacy in acute lung ingury model. ACT-660602 can be used for autoimmune diseases research.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.